Sandoz Mobile Health Initiative: Empowering Com...

By João L. Carapinha

May 5, 2026

Sandoz has launched the Sandoz mobile health initiative in Portugal through its “Sandoz em Marcha” project, sending a mobile health unit to 16 localities over two...
Economic Impact of Fragmented Care: Tackling Obesity, Diabetes, and Cardiovas...
Escalating Public Spending: Semaglutide Off-Label Use Sparks €250 Million Fra...
Semaglutide Distribution Flexibility: EMA Approves Room Temperature Delivery ...
Differentiated Visceral Fat Reduction in Early Trials of WVE-007
Enhancing Obesity Treatment Pricing in South Africa Through Competitive Strat...
Semaglutide India Partnership: Enhancing Access to Diabetes Treatment
Wegovy HD Approval: A Game Changer in Obesity Treatment and Weight Loss Efficacy
FDA Warning Letter Novo Nordisk Reveals Serious Compliance Failures in Advers...
Novo Nordisk Announces Semaglutide Price Reduction to Improve Patient Access
European Commission Approves Enhanced Wegovy Obesity Treatment Dose
South Africa Health Reform: Navigating Innovations and Challenges for 2026
Surge in Obesity Intervention Costs in the Netherlands